Alterations in LCFAs of IMQ-treated WT and Tcrd−/− mice suggest a potential association between the pivotal pathogenic factor IL-17A and the abnormal metabolism of LCFAs among psoriasis patients. This evidence concerns the gene IL17A and psoriasis.